Cytokinetics, Inc. (CYTK)
72.09
-5.81
(-7.46%)
USD |
NASDAQ |
Aug 28, 16:00
72.11
+0.02
(+0.03%)
After-Hours: 20:00
Cytokinetics 30-Day Average Daily Volume : 1.834M for Aug. 28, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| August 28, 2026 | 1.834M |
| August 27, 2026 | 1.741M |
| August 26, 2026 | 1.751M |
| August 25, 2026 | 1.754M |
| August 24, 2026 | 1.760M |
| August 21, 2026 | 1.783M |
| August 20, 2026 | 1.791M |
| August 19, 2026 | 1.792M |
| August 18, 2026 | 1.822M |
| August 17, 2026 | 1.843M |
| August 14, 2026 | 1.868M |
| August 13, 2026 | 1.877M |
| August 12, 2026 | 1.889M |
| August 11, 2026 | 1.899M |
| August 10, 2026 | 1.978M |
| August 07, 2026 | 2.141M |
| August 06, 2026 | 2.101M |
| August 05, 2026 | 2.098M |
| August 04, 2026 | 2.114M |
| August 03, 2026 | 2.128M |
| July 31, 2026 | 2.172M |
| July 30, 2026 | 2.231M |
| July 29, 2026 | 2.293M |
| July 28, 2026 | 2.268M |
| July 27, 2026 | 2.255M |
| Date | Value |
|---|---|
| July 24, 2026 | 2.242M |
| July 23, 2026 | 2.235M |
| July 22, 2026 | 2.282M |
| July 21, 2026 | 2.292M |
| July 20, 2026 | 2.305M |
| July 17, 2026 | 2.300M |
| July 16, 2026 | 2.300M |
| July 15, 2026 | 2.303M |
| July 14, 2026 | 2.314M |
| July 13, 2026 | 2.328M |
| July 10, 2026 | 2.330M |
| July 09, 2026 | 2.325M |
| July 08, 2026 | 2.324M |
| July 07, 2026 | 2.282M |
| July 06, 2026 | 2.265M |
| July 02, 2026 | 2.269M |
| July 01, 2026 | 2.282M |
| June 30, 2026 | 2.270M |
| June 29, 2026 | 2.251M |
| June 26, 2026 | 2.208M |
| June 25, 2026 | 2.043M |
| June 24, 2026 | 2.044M |
| June 23, 2026 | 2.140M |
| June 22, 2026 | 2.264M |
| June 18, 2026 | 2.448M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Bristol Myers Squibb Co. | 10.81M |
| Krystal Biotech, Inc. | 458407.6 |
| Ionis Pharmaceuticals, Inc. | 2.678M |
| Vertex Pharmaceuticals, Inc. | 1.235M |
| Alnylam Pharmaceuticals, Inc. | 2.050M |